CELL AND GENE THERAPY INSIGHTS

October 2019 Issue

Volume 5 Issue 10

Cell and Gene Therapy Insights Volume 5 Issue 10
Download PDF

Featuring

Issue Spotlight: Decentralized Manufacture
Vectors focus: Raw Materials 2019
Other articles
Webinars

SPOTLIGHT

Decentralized Manufacture
Nicholas Medcalf
Guest Editor:
Nicholas Medcalf, Deputy Challenge Director at Innovate UK

Research Article

Regenerative medicine as a disruptive technology: implications for manufacturing & clinical adoption

Regenerative medicine as a disruptive technology: implications for manufacturing & clinical adoption

Geoffrey Banda, Joyce Tait, James Mittra
23 October 2019
Read

Expert Insight

Decentralized manufacture of cell therapies: the challenge of operational modeling

Decentralized manufacture of cell therapies: the challenge of operational modeling

Nicholas Medcalf
23 October 2019
Read
Cell manufacturability

Cell manufacturability

Masahiro Kino-oka, Manabu Mizutani, Nicholas Medcalf
21 October 2019
Read
Implementation of advanced therapy medicinal products: a UK pharmacist’s perspective

Implementation of advanced therapy medicinal products: a UK pharmacist’s perspective

Anne Black
18 October 2019
Read
Regulatory considerations for decentralized manufacture of ATMPs

Regulatory considerations for decentralized manufacture of ATMPs

Alison Wilson, Alexis Cockroft
2 October 2019
Read
Decentralized manufacturing and institutional readiness: adoption as a distributed process

Decentralized manufacturing and institutional readiness: adoption as a distributed process

Andrew Webster
13 September 2019
Read

Interview

Building flexibility into GMP CAR T cell therapy manufacture

Building flexibility into GMP CAR T cell therapy manufacture

Christin Tischner
18 November 2019
Read
Challenges in demonstrating comparability in the decentralized manufacturing environment

Challenges in demonstrating comparability in the decentralized manufacturing environment

Jonathan Campbell
16 October 2019
Read
Pros and cons of point of care manufacture of cellular cancer immunotherapies

Pros and cons of point of care manufacture of cellular cancer immunotherapies

Linda Kelley
13 September 2019
Read

Vectors FOCUS

Raw Materials 2019

Perspective

ATMP raw materials: ‘the plasmid conundrum’

ATMP raw materials: ‘the plasmid conundrum’

Alan Griffith
17 October 2019
Read

Interview

Challenges in viral vector raw materials procurement & management

Challenges in viral vector raw materials procurement & management

Kathleen Szczur
1 November 2019
Read
Identifying and mitigating risks in the viral vector supply chain

Identifying and mitigating risks in the viral vector supply chain

Claire Wartel-Weill, Ulises Villavicencio
1 November 2019
Read
Major bioprocessing challenges & considerations with gene therapies and ex vivo gene-edited cell therapy

Major bioprocessing challenges & considerations with gene therapies and ex vivo gene-edited cell therapy

Andy Ramelmeier
1 November 2019
Read

Podcast

Identifying and mitigating risks in the viral vector supply chain - Podcast

Identifying and mitigating risks in the viral vector supply chain - Podcast

Claire Wartel-Weill, Ulises Villavicencio
1 November 2019
Listen

Journal articles

Commercial Insights

Cell & Gene Therapy Commercial Insight – September 2019

Cell & Gene Therapy Commercial Insight – September 2019

Mark Curtis, Richard Philipson
30 October 2019
Read

Webinars